Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 172

1.

Vaccination against cytomegalovirus: Still at base camp?

Emery VC.

Am J Transplant. 2018 Dec;18(12):2847-2848. doi: 10.1111/ajt.14969. Epub 2018 Jun 22. No abstract available.

PMID:
29894027
2.

Towards an ultra-rapid smartphone- connected test for infectious diseases.

Turbé V, Gray ER, Lawson VE, Nastouli E, Brookes JC, Weiss RA, Pillay D, Emery VC, Verrips CT, Yatsuda H, Athey D, McKendry RA.

Sci Rep. 2017 Sep 20;7(1):11971. doi: 10.1038/s41598-017-11887-6.

3.

Correction: Randomized Controlled Trials to Define Viral Load Thresholds for Cytomegalovirus Pre-Emptive Therapy.

Griffiths PD, Rothwell E, Raza M, Wilmore S, Doyle T, Harber M, O'Beirne J, Mackinnon S, Jones G, Thorburn D, Mattes F, Nebbia G, Atabani S, Smith C, Stanton A, Emery VC.

PLoS One. 2017 Sep 19;12(9):e0185298. doi: 10.1371/journal.pone.0185298. eCollection 2017.

4.

Correction: Novel decay dynamics revealed for virus-mediated drug activation in cytomegalovirus infection.

Rose J, Emery VC, Kumar D, Asberg A, Hartmann A, Jardine AG, Bignamini AA, Humar A, Neumann AU.

PLoS Pathog. 2017 May 10;13(5):e1006386. doi: 10.1371/journal.ppat.1006386. eCollection 2017 May.

5.

Novel decay dynamics revealed for virus-mediated drug activation in cytomegalovirus infection.

Rose J, Emery VC, Kumar D, Asberg A, Hartmann A, Jardine AG, Bignamini AA, Humar A, Neumann AU.

PLoS Pathog. 2017 Apr 13;13(4):e1006299. doi: 10.1371/journal.ppat.1006299. eCollection 2017 Apr. Erratum in: PLoS Pathog. 2017 May 10;13(5):e1006386.

6.

Cytomegalovirus in pregnancy and the neonate.

Emery VC, Lazzarotto T.

F1000Res. 2017 Feb 14;6:138. doi: 10.12688/f1000research.10276.1. eCollection 2017. Review.

7.

Randomized Controlled Trials to Define Viral Load Thresholds for Cytomegalovirus Pre-Emptive Therapy.

Griffiths PD, Rothwell E, Raza M, Wilmore S, Doyle T, Harber M, O'Beirne J, Mackinnon S, Jones G, Thorburn D, Mattes F, Nebbia G, Atabani S, Smith C, Stanton A, Emery VC.

PLoS One. 2016 Sep 29;11(9):e0163722. doi: 10.1371/journal.pone.0163722. eCollection 2016. Erratum in: PLoS One. 2017 Sep 19;12 (9):e0185298.

8.

Compartmentalized dynamics of cytomegalovirus replication in treated congenital infection.

Luck SE, Emery VC, Atkinson C, Sharland M, Griffiths PD.

J Clin Virol. 2016 Sep;82:152-158. doi: 10.1016/j.jcv.2016.07.018. Epub 2016 Jul 27.

PMID:
27500364
9.

Effects of donor/recipient human leukocyte antigen mismatch on human cytomegalovirus replication following liver transplantation.

Aldridge RW, Mattes FM, Rolando N, Rolles K, Smith C, Shirling G, Atkinson C, Burroughs AK, Milne RS, Emery VC, Griffiths PD.

Transpl Infect Dis. 2015 Feb;17(1):25-32. doi: 10.1111/tid.12325. Epub 2015 Jan 9.

10.

Restimulating interest in cytomegalovirus as a cofactor for HIV infection.

Emery VC.

J Infect Dis. 2015 Jan 15;211(2):169-71. doi: 10.1093/infdis/jiu419. Epub 2014 Jul 31. No abstract available.

11.

Taming the transplantation troll by targeting terminase.

Griffiths PD, Emery VC.

N Engl J Med. 2014 May 8;370(19):1844-6. doi: 10.1056/NEJMe1401567. No abstract available.

PMID:
24806164
12.

Development of a novel single tube nested PCR for enhanced detection of cytomegalovirus DNA from dried blood spots.

Atkinson C, Emery VC, Griffiths PD.

J Virol Methods. 2014 Feb;196:40-4. doi: 10.1016/j.jviromet.2013.10.029. Epub 2013 Oct 30.

PMID:
24184085
13.

Age-associated increase of low-avidity cytomegalovirus-specific CD8+ T cells that re-express CD45RA.

Griffiths SJ, Riddell NE, Masters J, Libri V, Henson SM, Wertheimer A, Wallace D, Sims S, Rivino L, Larbi A, Kemeny DM, Nikolich-Zugich J, Kern F, Klenerman P, Emery VC, Akbar AN.

J Immunol. 2013 Jun 1;190(11):5363-72. doi: 10.4049/jimmunol.1203267. Epub 2013 May 1.

14.

CMV infected or not CMV infected: that is the question.

Emery VC.

Eur J Immunol. 2013 Apr;43(4):886-8. doi: 10.1002/eji.201343466.

15.

Human herpesvirus vaccines and future directions.

Emery VC.

Am J Transplant. 2013 Feb;13 Suppl 3:79-86; quiz 86. doi: 10.1111/ajt.12007.

16.

The "silent" global burden of congenital cytomegalovirus.

Manicklal S, Emery VC, Lazzarotto T, Boppana SB, Gupta RK.

Clin Microbiol Rev. 2013 Jan;26(1):86-102. doi: 10.1128/CMR.00062-12. Review.

17.

Response to letter regarding "cytomegalovirus replication kinetics in solid organ transplant recipients managed by preemptive therapy".

Atabani SF, Emery VC, Smith C, Harber M, Thorburn D, Griffiths PD.

Am J Transplant. 2012 Oct;12(10):2859-60. doi: 10.1111/j.1600-6143.2012.04227.x. No abstract available.

18.

Acute cytomegalovirus infection is associated with increased frequencies of activated and apoptosis-vulnerable T cells in HIV-1-infected infants.

Slyker JA, Rowland-Jones SL, Dong T, Reilly M, Richardson B, Emery VC, Atzberger A, Mbori-Ngacha D, Lohman-Payne BL, John-Stewart GC.

J Virol. 2012 Oct;86(20):11373-9. Epub 2012 Aug 8.

19.

Cytomegalovirus replication kinetics in solid organ transplant recipients managed by preemptive therapy.

Atabani SF, Smith C, Atkinson C, Aldridge RW, Rodriguez-Perálvarez M, Rolando N, Harber M, Jones G, O'Riordan A, Burroughs AK, Thorburn D, O'Beirne J, Milne RS, Emery VC, Griffiths PD.

Am J Transplant. 2012 Sep;12(9):2457-64. doi: 10.1111/j.1600-6143.2012.04087.x. Epub 2012 May 17.

20.

Importance of the cytomegalovirus seropositive recipient as a contributor to disease burden after solid organ transplantation.

Emery VC, Asher K, Sanjuan Cde J.

J Clin Virol. 2012 Jun;54(2):125-9. doi: 10.1016/j.jcv.2012.02.020. Epub 2012 Mar 22.

21.

Influence of cytomegalovirus infection on immune cell phenotypes in patients with common variable immunodeficiency.

Marashi SM, Raeiszadeh M, Enright V, Tahami F, Workman S, Chee R, Webster AD, Milne RS, Emery VC.

J Allergy Clin Immunol. 2012 May;129(5):1349-1356.e3. doi: 10.1016/j.jaci.2012.02.011. Epub 2012 Mar 22.

PMID:
22444511
22.

Differential decay kinetics of human cytomegalovirus glycoprotein B genotypes following antiviral chemotherapy.

Emery VC, Manuel O, Asberg A, Pang X, Kumar D, Hartmann A, Preiksaitis JK, Pescovitz MD, Rollag H, Jardine AG, Gahlemann CG, Humar A.

J Clin Virol. 2012 May;54(1):56-60. doi: 10.1016/j.jcv.2012.01.015. Epub 2012 Mar 10.

23.

Cytomegalovirus: recent progress in understanding pathogenesis and control.

Emery VC.

QJM. 2012 May;105(5):401-5. doi: 10.1093/qjmed/hcr262. Epub 2011 Dec 22. Review.

24.

Summary of the British Transplantation Society Guidelines for the Prevention and Management of CMV Disease After Solid Organ Transplantation.

Andrews PA, Emery VC, Newstead C.

Transplantation. 2011 Dec 15;92(11):1181-7. doi: 10.1097/TP.0b013e318235c7fc. Review.

PMID:
22002346
25.

Could a vaccine against immune-evading cytomegalovirus become a reality?

Emery VC.

Expert Rev Vaccines. 2011 Aug;10(8):1109-11. doi: 10.1586/erv.11.92. No abstract available.

PMID:
21854303
26.

Cytomegalovirus quantification: where to next in optimising patient management?

Atkinson C, Emery VC.

J Clin Virol. 2011 Aug;51(4):223-8. doi: 10.1016/j.jcv.2011.04.007. Epub 2011 May 28. Review.

PMID:
21620764
27.

Inflammation in common variable immunodeficiency is associated with a distinct CD8(+) response to cytomegalovirus.

Marashi SM, Raeiszadeh M, Workman S, Rahbar A, Soderberg-Naucler C, Klenerman P, Chee R, Webster AD, Milne RS, Emery VC.

J Allergy Clin Immunol. 2011 Jun;127(6):1385-93.e4. doi: 10.1016/j.jaci.2011.04.001. Epub 2011 May 4.

28.

Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial.

Griffiths PD, Stanton A, McCarrell E, Smith C, Osman M, Harber M, Davenport A, Jones G, Wheeler DC, O'Beirne J, Thorburn D, Patch D, Atkinson CE, Pichon S, Sweny P, Lanzman M, Woodford E, Rothwell E, Old N, Kinyanjui R, Haque T, Atabani S, Luck S, Prideaux S, Milne RS, Emery VC, Burroughs AK.

Lancet. 2011 Apr 9;377(9773):1256-63. doi: 10.1016/S0140-6736(11)60136-0.

29.

HHV-6A, 6B, and 7: persistence in the population, epidemiology and transmission.

Emery VC, Clark DA.

In: Arvin A, Campadelli-Fiume G, Mocarski E, Moore PS, Roizman B, Whitley R, Yamanishi K, editors. Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis. Cambridge: Cambridge University Press; 2007. Chapter 49.

30.

Immunotherapy and vaccination after transplant: the present, the future.

Emery VC, Einsele H, Atabani S, Haque T.

Hematol Oncol Clin North Am. 2011 Feb;25(1):215-29. doi: 10.1016/j.hoc.2010.11.014.

PMID:
21236399
31.

Human cytomegalovirus (HCMV) replication kinetics in stem cell transplant recipients following anti-HCMV therapy.

Buyck HC, Griffiths PD, Emery VC.

J Clin Virol. 2010 Sep;49(1):32-6. doi: 10.1016/j.jcv.2010.06.018. Epub 2010 Jul 27.

PMID:
20667769
32.

Sequential mutations associated with adaptation of human cytomegalovirus to growth in cell culture.

Dargan DJ, Douglas E, Cunningham C, Jamieson F, Stanton RJ, Baluchova K, McSharry BP, Tomasec P, Emery VC, Percivalle E, Sarasini A, Gerna G, Wilkinson GW, Davison AJ.

J Gen Virol. 2010 Jun;91(Pt 6):1535-46. doi: 10.1099/vir.0.018994-0.

33.

Immunotherapy and vaccination after transplant: the present, the future.

Emery VC, Einsele H, Atabani S, Haque T.

Infect Dis Clin North Am. 2010 Jun;24(2):515-29. doi: 10.1016/j.idc.2010.01.004. Review.

PMID:
20466281
34.

The effects of maribavir on the autophosphorylation of ganciclovir resistant mutants of the cytomegalovirus UL97 protein.

Shannon-Lowe CD, Emery VC.

Herpesviridae. 2010 Dec 7;1(1):4. doi: 10.1186/2042-4280-1-4.

35.

The risk of early and late CMV DNAemia associated with Campath use in stem cell transplant recipients.

Buyck HC, Prentice HG, Griffiths PD, Emery VC.

Bone Marrow Transplant. 2010 Jul;45(7):1212-9. doi: 10.1038/bmt.2009.329. Epub 2009 Dec 7.

36.

Sequence flexibility of the immunodominant HLA A*0201 restricted ppUL83 CD8 T-cell epitope of human cytomegalovirus.

Kopycinski J, Osman M, Griffiths PD, Emery VC.

J Med Virol. 2010 Jan;82(1):94-103. doi: 10.1002/jmv.21668.

PMID:
19950243
37.

Extensive human cytomegalovirus (HCMV) genomic DNA in the renal tubular epithelium early after renal transplantation: Relationship with HCMV DNAemia and long-term graft function.

Li YT, Emery VC, Surah S, Jarmulowicz M, Sweny P, Kidd IM, Griffiths PD, Clark DA.

J Med Virol. 2010 Jan;82(1):85-93. doi: 10.1002/jmv.21662.

PMID:
19950242
38.

Impact of genetic polymorphisms in cytomegalovirus glycoprotein B on outcomes in solid-organ transplant recipients with cytomegalovirus disease.

Manuel O, Asberg A, Pang X, Rollag H, Emery VC, Preiksaitis JK, Kumar D, Pescovitz MD, Bignamini AA, Hartmann A, Jardine AG, Humar A.

Clin Infect Dis. 2009 Oct 15;49(8):1160-6. doi: 10.1086/605633.

PMID:
19751151
39.

Acute cytomegalovirus infection in Kenyan HIV-infected infants.

Slyker JA, Lohman-Payne BL, John-Stewart GC, Maleche-Obimbo E, Emery S, Richardson B, Dong T, Iversen AK, Mbori-Ngacha D, Overbaugh J, Emery VC, Rowland-Jones SL.

AIDS. 2009 Oct 23;23(16):2173-81. doi: 10.1097/QAD.0b013e32833016e8.

40.

The detection of cytomegalovirus DNA in maternal plasma is associated with mortality in HIV-1-infected women and their infants.

Slyker JA, Lohman-Payne BL, Rowland-Jones SL, Otieno P, Maleche-Obimbo E, Richardson B, Farquhar C, Mbori-Ngacha D, Emery VC, John-Stewart GC.

AIDS. 2009 Jan 2;23(1):117-24. doi: 10.1097/QAD.0b013e32831c8abd.

41.

Polyfunctional cytomegalovirus-specific CD4+ and pp65 CD8+ T cells protect against high-level replication after liver transplantation.

Nebbia G, Mattes FM, Smith C, Hainsworth E, Kopycinski J, Burroughs A, Griffiths PD, Klenerman P, Emery VC.

Am J Transplant. 2008 Dec;8(12):2590-9. doi: 10.1111/j.1600-6143.2008.02425.x. Epub 2008 Oct 6. Erratum in: Am J Transplant. 2011 May;11(5):1107.

42.

Genotypic analysis of two hypervariable human cytomegalovirus genes.

Bradley AJ, Kovács IJ, Gatherer D, Dargan DJ, Alkharsah KR, Chan PK, Carman WF, Dedicoat M, Emery VC, Geddes CC, Gerna G, Ben-Ismaeil B, Kaye S, McGregor A, Moss PA, Pusztai R, Rawlinson WD, Scott GM, Wilkinson GW, Schulz TF, Davison AJ.

J Med Virol. 2008 Sep;80(9):1615-23. doi: 10.1002/jmv.21241.

43.

Impact of HIV on host-virus interactions during early hepatitis C virus infection.

Danta M, Semmo N, Fabris P, Brown D, Pybus OG, Sabin CA, Bhagani S, Emery VC, Dusheiko GM, Klenerman P.

J Infect Dis. 2008 Jun 1;197(11):1558-66. doi: 10.1086/587843.

PMID:
18419344
44.

Functional impairment of cytomegalovirus specific CD8 T cells predicts high-level replication after renal transplantation.

Mattes FM, Vargas A, Kopycinski J, Hainsworth EG, Sweny P, Nebbia G, Bazeos A, Lowdell M, Klenerman P, Phillips RE, Griffiths PD, Emery VC.

Am J Transplant. 2008 May;8(5):990-9. doi: 10.1111/j.1600-6143.2008.02191.x. Epub 2008 Mar 4. Erratum in: Am J Transplant. 2011 May;11(5):1107.

45.

Congenital cytomegalovirus: association between dried blood spot viral load and hearing loss.

Walter S, Atkinson C, Sharland M, Rice P, Raglan E, Emery VC, Griffiths PD.

Arch Dis Child Fetal Neonatal Ed. 2008 Jul;93(4):F280-5. Epub 2007 Nov 26.

PMID:
18039747
46.

Differential effects of prednisolone and azathioprine on the development of human cytomegalovirus replication post liver transplantation.

Nebbia G, Mattes FM, Sabin CA, Samonakis D, Rolando N, Burroughs AK, Emery VC.

Transplantation. 2007 Sep 15;84(5):605-10.

PMID:
17876273
47.

The ESCRT machinery is not required for human cytomegalovirus envelopment.

Fraile-Ramos A, Pelchen-Matthews A, Risco C, Rejas MT, Emery VC, Hassan-Walker AF, Esteban M, Marsh M.

Cell Microbiol. 2007 Dec;9(12):2955-67. Epub 2007 Aug 29.

PMID:
17760879
48.

Exploring the bidirectional interactions between human cytomegalovirus and hepatitis C virus replication after liver transplantation.

Nebbia G, Mattes FM, Cholongitas E, Garcia-Diaz A, Samonakis DN, Burroughs AK, Emery VC.

Liver Transpl. 2007 Jan;13(1):130-5.

49.

Detection of cytomegalovirus in human placental cells by polymerase chain reaction.

Paradowska E, Przepiórkiewicz M, Nowakowska D, Studzińska M, Wilczyński J, Emery VC, Leśnikowski ZJ.

APMIS. 2006 Nov;114(11):764-71.

PMID:
17078856
50.

Modelling cytomegalovirus replication patterns in the human host: factors important for pathogenesis.

Regoes RR, Bowen EF, Cope AV, Gor D, Hassan-Walker AF, Prentice HG, Johnson MA, Sweny P, Burroughs AK, Griffiths PD, Bonhoeffer S, Emery VC.

Proc Biol Sci. 2006 Aug 7;273(1596):1961-7.

Supplemental Content

Loading ...
Support Center